Does Esomeprazole Magnesium Delayed Release Capsules Interact with Mycophenolate Mofetil?
Esomeprazole Magnesium Delayed Release Capsules and Mycophenolate Mofetil have a moderate drug interaction according to U.S. FDA drug labeling data. Esomeprazole magnesium may interfere with mycophenolate mofetil bioavailability due to effects on gastric pH. The mechanism involves increased gastric ph affects drug bioavailability. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This information is based on official FDA drug labeling sourced from OpenFDA and the NIH National Library of Medicine.
- Severity
- Moderate
- Management
- Monitor for effects
- Data Source
- U.S. FDA via OpenFDA
How This Interaction Works
The interaction between Esomeprazole Magnesium Delayed Release Capsules and Mycophenolate Mofetil occurs because increased gastric ph affects drug bioavailability. Clinically, this means esomeprazole magnesium may interfere with mycophenolate mofetil bioavailability due to effects on gastric ph. This is classified as a moderate interaction. While it may not require stopping either medication, your healthcare provider should be aware you are taking both so they can monitor for potential effects and adjust treatment if necessary.
What To Tell Your Doctor or Pharmacist
If you are taking Esomeprazole Magnesium Delayed Release Capsules and your doctor is considering prescribing Mycophenolate Mofetil (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider